您的位置: 首页 > 农业专利 > 详情页

СПОСОБЫ ЛЕЧЕНИЯ РАКА С ПРИМЕНЕНИЕМ ИНГИБИТОРА АУТОФАГИИ НА ОСНОВЕ ТИОКСАНТОНА
专利权人:
СПЕКТРУМ ФАРМАСЬЮТИКАЛЗ; ИНК. (US)
发明人:
НАВРОЦКИ Стефан Т. (US),КЭРЬЮ Дженнифер С. (US),РЕДДИ Гуру (US)
申请号:
RU2012135396/15
公开号:
RU2012135396A
申请日:
2011.03.08
申请国别(地区):
RU
年份:
2014
代理人:
摘要:
1. A method for treating cancer comprising: a) administering to a mammal in need thereof an effective amount of an autophagy inhibitor based on thioxanthone and b) administering to a mammal in need thereof an effective amount of a caller autophagy compounds for treating cancer, wherein the administration as an autophagy inhibitor based on thioxanthone and causing autophagy compounds for treating cancer reduces a symptom associated with cancer, ensuring thereby treating cancer. 2. The method of claim 1, wherein the autophagy inhibitor based on thioxanthone represents 1 - ((2- (diethylamino) ethyl) amino) -4-methylthioxanthen-9-one, 1- (2-diethylaminoethylamino) -4- ( hydroxymethyl) -9-thioxanthenone, N - [[1 - [[2- (diethylamino) ethyl] amino] -9-oxo-9H-tiaksanten-4-yl] methyl] methanesulfonamide, its analogues or indazole soli.3. A method according to claim 1, characterized in that the calling autophagy compound for the treatment of cancer is arsenic trioxide, etoposide, rapamycin, histone deacetylase inhibitor, tyrosine kinase inhibitors, tamoxifen, temozolomide, or imatinib bortezomib.4. A method according to claim 3, wherein the histone deacetylase inhibitor is a histone deacetylase inhibitor hydroxamated type or histone deacetylase inhibitor tipa.5 benzamide. A method according to claim 3, wherein the histone deacetylase inhibitor is (2E, 4E, 6R) -7- (4-dimethylaminophenyl) -N-hydroxy-4,6-dimethyl-7-oxoheptyl 2,4-dienamide, N-hydroxy-N-feniloktandiamid, 4-dimethylamino-N- (6-gidroksikarbamoilgeksil) benzamide, N-hydroxy-3 - [(E) -3- (hydroxyamino) -3-oxoprop-1-enyl] -benzamide (2E) -3- [3- (anilinosulfonil) phenyl] -N-gidroksiakrilamid, ((E) -N-hydroxy-3- [4 - [[2-hydroxyethyl- [2- (1H-indol-3-yl ) e1. Способ лечения рака, включающий:a) введение млекопитающему, нуждающемуся в этом, эффективного количества ингибитора аутофагии на основе тиоксантона иb) введение млекопитающему, нуждающемуся в этом, эффективного количества вызывающего аутофагию соединения для лечен
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充